$莱斯康制药(LXRX)$ 8-K - Current report Filed: 2019-04-26 AccNo: 0001062822-19-000012 Size: 163 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01: Financial Statements and Exhibits 网页链接